Funds holding CENTESSA PHARMACEUTICALS PLC
ISIN US1523091007 · United States · LEI 213800GIDAARDSKOI827
- Fund holders
- 68
- Of which ETFs
- 12 56 other funds
- Value held
- 731M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 4,422,431 | 175.7M $ | 0.22 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 2,187,494 | 58.8M $ | 1.10 % | as of Feb 28, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 1,650,000 | 44.3M $ | 0.72 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,367,577 | 54.3M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 1,321,353 | 52.5M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 1,236,100 | 48.7M $ | 1.05 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 800,000 | 21.5M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 787,000 | 31M $ | 1.08 % | as of Apr 30, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 702,200 | 27.9M $ | 0.35 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 668,142 | 26.5M $ | 1.67 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 520,762 | 20.7M $ | 0.25 % | as of Mar 31, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 520,000 | 20.7M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 308,319 | 12.2M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Capital Group U.S. Small and Mid Cap ETF Capital Group Equity ETF Trust I | 297,652 | 8M $ | 0.48 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 292,644 | 11.6M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 285,000 | 11.3M $ | 1.13 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 279,689 | 11.1M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 272,448 | 10.8M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Dunham Monthly Distribution Fund Dunham Funds | 179,328 | 7.1M $ | 2.50 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 159,538 | 6.3M $ | 0.15 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 151,161 | 6M $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 151,000 | 4.1M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Mid Cap II Fund Fidelity Advisor Series I | 148,100 | 5.9M $ | 0.35 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Fund ROYCE FUND | 143,468 | 5.7M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| VIP Stock Selector Portfolio Variable Insurance Products Fund | 110,000 | 4.4M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 103,300 | 2.8M $ | 0.13 % | as of Feb 28, 2026 ↗ |
| Small Cap Growth Fund VALIC Co I | 100,112 | 2.7M $ | 0.50 % | as of Feb 28, 2026 ↗ |
| Eaton Vance Worldwide Health Sciences Fund Eaton Vance Growth Trust | 91,966 | 2.5M $ | 0.29 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 83,369 | 3.3M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 79,478 | 3.2M $ | 0.20 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 69,000 | 1.9M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Large-Cap Growth Portfolio PACIFIC SELECT FUND | 62,928 | 2.5M $ | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 60,171 | 1.6M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| American Funds U.S. Small & Mid Cap Equity Fund American Funds U.S. Small & Mid Cap Equity Fund | 52,339 | 1.4M $ | 0.36 % | as of Feb 28, 2026 ↗ |
| Fidelity Fundamental Small-Mid Cap ETF Fidelity Covington Trust | 45,948 | 1.8M $ | 0.14 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 43,775 | 1.7M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Small-Cap Growth Portfolio PACIFIC SELECT FUND | 42,270 | 1.7M $ | 0.38 % | as of Mar 31, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 38,812 | 1.5M $ | 0.07 % | as of Apr 30, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 36,486 | 1.4M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 31,457 | 1.2M $ | 0.55 % | as of Mar 31, 2026 ↗ |
| Alger Small Cap Growth Portfolio ALGER PORTFOLIOS | 29,578 | 1.2M $ | 0.90 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Diversified Stock Fund Fidelity Destiny Portfolios | 27,200 | 1.1M $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 27,166 | 729.7K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 26,339 | 1M $ | 1.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 22,800 | 612.4K $ | 1.01 % | as of Feb 28, 2026 ↗ |
| Morningstar Alternatives Fund Morningstar Funds Trust | 22,700 | 894.8K $ | 0.35 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 22,606 | 897.9K $ | 0.56 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 21,808 | 866.2K $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 18,754 | 739.3K $ | 0.24 % | as of Apr 30, 2026 ↗ |
| Variable Portfolio - Partners Small Cap Growth Fund Columbia Funds Variable Series Trust II | 15,309 | 608.1K $ | 0.18 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Fund Trust for Professional Managers | 14,054 | 377.5K $ | 0.07 % | as of Feb 28, 2026 ↗ |
| Penn Series Small Cap Growth Fund Penn Series Funds Inc | 13,936 | 553.5K $ | 0.63 % | as of Mar 31, 2026 ↗ |
| U.S. Small and Mid Cap Equity Fund AMERICAN FUNDS INSURANCE SERIES | 13,879 | 551.3K $ | 0.57 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 12,472 | 335K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 11,382 | 452.1K $ | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Puritan K6 Fund Fidelity Puritan Trust | 10,706 | 287.6K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 10,411 | 410.4K $ | 1.10 % | as of Apr 30, 2026 ↗ |
| Guardian Large Cap Fundamental Growth VIP Fund Guardian Variable Products Trust | 7,800 | 309.8K $ | 0.21 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 5,405 | 145.2K $ | 0.19 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 4,605 | 123.7K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,455 | 119.7K $ | 0.13 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 3,013 | 80.9K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,990 | 79K $ | 0.39 % | as of Mar 31, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 1,874 | 74.4K $ | 1.59 % | as of Mar 31, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 1,150 | 30.9K $ | 0.35 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 871 | 34.6K $ | 0.23 % | as of Mar 31, 2026 ↗ |
| Comstock Capital Value Fund Comstock Funds, Inc. | 500 | 19.9K $ | 0.19 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Moderate Allocation Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 459 | 18.2K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Dunham Monthly Distribution Fund Dunham Funds | 2.50 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.67 % | as of Mar 31, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 1.59 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 1.13 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 1.11 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.10 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1.10 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 1.08 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 1.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.01 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 68 | +2 | 20,256,039 | +6.4 % |
| 2026Q1 | 66 | +8 | 19,036,743 | +21.0 % |
| 2025Q4 | 58 | +11 | 15,729,308 | +12.5 % |
| 2025Q3 | 47 | 0 | 13,981,177 | +11.5 % |
| 2025Q2 | 47 | +2 | 12,543,849 | -6.6 % |
| 2025Q1 | 45 | +5 | 13,428,989 | +11.7 % |
| 2024Q4 | 40 | +16 | 12,027,494 | +48.7 % |
| 2024Q3 | 24 | 0 | 8,087,773 | +14.2 % |
| 2024Q2 | 24 | +6 | 7,080,116 | +9.4 % |
| 2024Q1 | 18 | +1 | 6,468,895 | +4.0 % |
| 2023Q4 | 17 | 6,221,961 |
Institutional managers
160 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | 792.9M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 11,430,455 | 454M $ | as of Mar 31, 2026 |
| Index Venture Life Associates VI Ltd | 9,961,789 | 395.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8,925,010 | 354.5M $ | as of Mar 31, 2026 |
| Pentwater Capital Management LP | 8,170,000 | 324.5M $ | as of Mar 31, 2026 |
| FMR LLC | 6,852,047 | 272.2M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 6,000,000 | 238.3M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 5,258,903 | 208.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 4,832,548 | 191.9M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 4,809,000 | 191M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 4,286,480 | 170.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 4,268,353 | 169.5M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 3,574,048 | 142M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 3,492,977 | 138.7M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 3,158,041 | 125.4M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,125,000 | 84.4M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,054,175 | 81.6M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 2,049,439 | 81.4M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,986,768 | 78.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,932,406 | 76.8M $ | as of Mar 31, 2026 |
| MAVERICK CAPITAL LTD | 1,854,488 | 73.7M $ | as of Mar 31, 2026 |
| First Light Asset Management, LLC | 1,560,991 | 62M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 1,400,000 | 55.6M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 1,364,019 | 54.2M $ | as of Mar 31, 2026 |
| GENERAL ATLANTIC, L.P. | 1,354,830 | 53.8M $ | as of Mar 31, 2026 |
Declared shareholders of CENTESSA PHARMACEUTICALS PLC
5 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 7.50 % | 6,783,047 | as of Mar 31, 2026 · SCHEDULE 13G |
| Avoro Capital Advisors LLC and 1 other | 7.39 % | 11,430,455 | as of Mar 31, 2026 · SCHEDULE 13G |
| Adage Capital Management, L.P. and 2 others | 5.77 % | 8,925,010 | as of Mar 31, 2026 · SCHEDULE 13G |
| Pentwater Capital Management LP and 1 other | 5.30 % | 8,170,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| FARALLON CAPITAL MANAGEMENT, L.L.C. and 15 others | 0.00 % | 0 | as of Jun 24, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding CENTESSA PHARMACEUTICALS PLC". https://titelia.com/en/stocks/centessa-pharmaceuticals-plc-US1523091007